- Home
- CLLS vs SXC Comparison
CLLS vs SXC Comparison
Compare CLLS & SXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLLS | SXC |
|---|---|---|
| Founded | 1999 | 1960 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 476.5M | 549.5M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLLS | SXC |
|---|---|---|
| Price | $4.99 | $7.18 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $8.50 | ★ $10.00 |
| AVG Volume (30 Days) | 112.6K | ★ 1.3M |
| Earning Date | 11-07-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 6.67% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.75 |
| Revenue | $82,551,000.00 | ★ $1,843,100,000.00 |
| Revenue This Year | $32.58 | N/A |
| Revenue Next Year | $20.68 | $4.94 |
| P/E Ratio | ★ N/A | $9.60 |
| Revenue Growth | ★ 129.04 | N/A |
| 52 Week Low | $1.10 | $6.24 |
| 52 Week High | $5.48 | $10.89 |
Technical Indicators
Market Signals| Indicator | CLLS | SXC |
|---|---|---|
| Relative Strength Index (RSI) | 57.74 | 55.30 |
| Support Level | $4.67 | $7.09 |
| Resistance Level | $5.03 | $7.33 |
| Average True Range (ATR) | 0.28 | 0.20 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 67.51 | 63.16 |
Price Performance
Historical ComparisonAbout CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About SXC SunCoke Energy Inc.
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is primarily used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through three segments: Domestic Coke, Brazil Coke, and Logistics. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.